Showing results (181-190 of 206) with videos related to
Sort By:
Pageof 21
AIDS Research and Human Retroviruses|March 1, 1995
Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retrovirusesM P Sherman, N L Dock, G D Ehrlich, et al.Science (New York, N.Y.)|November 3, 2001
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 VprC M de Noronha, M P Sherman, H W Lin, et al.Biochemistry|April 13, 2001
The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segmentM V Sawai, H P Jia, L Liu, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|October 13, 2001
Direct and indirect bacterial killing functions of neutrophil defensins in lung explantsG A Porro, J H Lee, J de Azavedo, et al.Leukemia Research|June 1, 1994
Prototypical HTLV-I/II infection is rare in LGL leukemiaT P Loughran, M P Sherman, F W Ruscetti, et al.Journal of Periodontal Research|October 5, 2001
Localized antimicrobial peptide expression in human gingivaB A Dale, J R Kimball, S Krisanaprakornkit, et al.Biochemical Pharmacology|March 1, 1988
Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophilsP A Charp, W G Rice, R L Raynor, et al.The Journal of Biological Chemistry|July 21, 2000
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrestP Henklein, K Bruns, M P Sherman, et al.Blood|June 15, 1997
Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cellsA A Higazi, E Lavi, K Bdeir, et al.Virology|December 1, 1993
High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of ArgentinaJ F Ferrer, N Del Pino, E Esteban, et al.Pageof 21